Opioid and Other Substance Use Disorders Study Committee. Section 1 of the bill excludes injuries involving the possession of drugs or drug paraphernalia from a physician's mandatory reporting requirements. Sections 2 and 3 clarify that the civil and criminal immunity that
protects a person who acts in good faith to furnish or administer an opioid antagonist also protects a person who distributes the opioid antagonist. Section 4 adds an exemption to the prohibition on possessing drug
paraphernalia for possession of drug paraphernalia that a person received from an approved syringe exchange program or a program carried out by a harm reduction organization while the person was participating in the program. Section 5 specifies that money appropriated to the department of
public health and environment to purchase non-laboratory synthetic opiate detection tests may also be used to purchase other drug testing equipment. Section 6 authorizes an organization operating a clean syringe
exchange program to provide drug testing services through the program. Sections 7 though 23 are conforming amendments that update the
term opiate antagonist to opioid antagonist.
